RFA-CA-21-005 - Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 1

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Innovative Molecular Analysis Technologies for Low-Resource Settings Globally NOT-CA-21-025 NCI Jan 4, 2021 Sep 30, 2021 R21
For technical issues E-mail OER Webmaster